John F. Sargent, Jr.
Specialist in Science and Technology Policy
Nanoscale science, engineering, and technology—commonly referred to collectively as nanotechnology—is believed by many to offer extraordinary economic and societal benefits. Congress has demonstrated continuing support for nanotechnology and has directed its attention primarily to three topics that may affect the realization of this hoped for potential: federal research and development (R&D) in nanotechnology; U.S. competitiveness; and environmental, health, and safety (EHS) concerns. This report provides an overview of these topics—which are discussed in more detail in other CRS reports—and two others: nanomanufacturing and public understanding of and attitudes toward nanotechnology.
The development of this emerging field has been fostered by significant and sustained public investments in nanotechnology R&D. Nanotechnology R&D is directed toward the understanding and control of matter at dimensions of roughly 1 to 100 nanometers. At this size, the properties of matter can differ in fundamental and potentially useful ways from the properties of individual atoms and molecules and of bulk matter. Since the launch of the National Nanotechnology Initiative (NNI) in 2000 through FY2013, Congress has appropriated approximately $18 billion for nanotechnology R&D. President Obama has requested $1.7 billion in NNI funding for FY2014. More than 60 nations have established similar programs. In 2010, total annual global public R&D investments reached an estimated $8.2 billion, complemented by an estimated private sector investment of $9.6 billion. Data on economic outputs used to assess competitiveness in mature technologies and industries, such as revenues and market share, are not available for assessing nanotechnology. Alternatively, data on inputs (e.g., R&D expenditures) and non-financial outputs (e.g., scientific papers, patents) may provide insight into the current U.S. position and serve as bellwethers of future competitiveness. By these criteria, the United States appears to be the overall global leader in nanotechnology, though some believe the U.S. lead may not be as large as it was for previous emerging technologies.
Some research has raised concerns about the safety of nanoscale materials. There is general agreement that more information on EHS implications is needed to protect the public and the environment; to assess and manage risks; and to create a regulatory environment that fosters prudent investment in nanotechnology-related innovation. Nanomanufacturing—the bridge between nanoscience and nanotechnology products—may require the development of new technologies, tools, instruments, measurement science, and standards to enable safe, effective, and affordable commercial-scale production of nanotechnology products. Public understanding and attitudes may also affect the environment for R&D, regulation, and market acceptance of products incorporating nanotechnology.
In 2003, Congress enacted the 21st Century Nanotechnology Research and Development Act (P.L. 108-153) providing a legislative foundation for some of the activities of the NNI, addressing concerns, establishing programs, assigning agency responsibilities, and setting authorization levels. Efforts to reauthorize the act have been unsuccessful. As of the date of this report, no reauthorization legislation had been introduced in the 113th Congress. In October 2013, the ranking member of the House Committee on Science, Space, and Technology circulated a draft reauthorization of the America COMPETES Act that included a “Reauthorization of the National Nanotechnology Initiative” subtitle. The majority version of the 2013 America COMPETES Act reauthorization bill does not include a nanotechnology reauthorization provision.
Date of Report: December 16, 2013
Number of Pages: 17
Order Number: RL34511
Price: $29.95
To Order:
CLICK: RL34511.pdf to use the SECURE SHOPPING CART
e-mail congress@pennyhill.com
Phone 301-253-0881
For email and phone orders, provide a Visa, MasterCard, American Express, or Discover card number, expiration date, and name on the card. Indicate whether you want e-mail or postal delivery.
Nanotechnology: A Policy Primer - RL34511
